• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 10-K/A filed by Israel Acquisitions Corp

    6/23/25 10:57:53 AM ET
    $ISRL
    Blank Checks
    Finance
    Get the next $ISRL alert in real time by email
    false --12-31 2024 FY 0001915328 0001915328 2024-01-01 2024-12-31 0001915328 isrlu:UnitsEachConsistingOfOneClassaOrdinaryShareAndOneRedeemableWarrantMember 2024-01-01 2024-12-31 0001915328 isrlu:ClassaOrdinarySharesParValue0.0001PerShareMember 2024-01-01 2024-12-31 0001915328 isrlu:RedeemableWarrantsEachWholeWarrantExercisableForOneClassaOrdinaryShareEachAtExercisePriceOf11.50PerShareMember 2024-01-01 2024-12-31 0001915328 2024-06-28 0001915328 2025-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 10-K/A

    (Amendment No. 1)

     

     

     

    (Mark One)

     

    x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the fiscal year ended: December 31, 2024

     

    ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from _______________________ to ____________________________________

     

    Commission File Number: 001-41593

     

    ISRAEL ACQUISITIONS CORP

    (Exact name of registration as specified in its charter)

     

    Cayman Islands   87-3587394
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    12600 Hill Country Blvd, Building R, Suite 275  
    Bee Cave, Texas 78738
    (Address of principal executive offices) (Zip Code)

     

    (800) 508-1531
    (Registrant’s telephone number, including area code)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange on
    which registered
    Units, each consisting of one Class A ordinary share and one redeemable warrant   ISRLU   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   ISRL   The Nasdaq Stock Market LLC
    Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share   ISRLW   The Nasdaq Stock Market LLC

     

    Securities registered pursuant to Section 12(g) of the Act: NONE

     

    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ¨ No  x

     

    Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ¨ No  x

     

    Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (17 CFR §232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

     

    Large Accelerated filer ¨ Accelerated filer ¨
    Non-accelerated filer x Smaller reporting company x
        Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨

     

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ¨

     

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).  ¨

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

     

    The aggregate market value of the ordinary shares held by non-affiliates of the registrant, computed as of June 28, 2024 (the last business day of the registrant’s most recently completed second fiscal quarter), was $79,855,765 (based on the $11.00 closing sale price of the Registrant’s Class A ordinary shares on such date).

     

    As of March 31, 2025, there were 1,560,432 Class A ordinary shares, par value $0.0001 per share issued and outstanding.

     

    Documents incorporated by reference:

     

    The Annual Report on Form 10-K filed by Israel Acquisitions Corp, filed with the United States Securities and Exchange Commission on March 31, 2025, is hereby incorporated by reference in its entirety (including into Parts I, II, and III).

     

    Auditor Firm IDAuditor NameAuditor Location
    243BDO USA, P.CNew York

     

     

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    Israel Acquisitions Corp (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) for the year ended December 31, 2024, to amend the Company’s Annual Report on Form 10-K, originally filed with the United States Securities and Exchange Commission on March 31, 2025 (the “Original 10-K”), and the Original 10-K is incorporated by reference herein. The Original Form 10-K omitted Exhibit 97.1, which is the Company’s Clawback Policy. The Company is filing this Amendment No. 1 solely to include the omitted exhibit.

     

    Pursuant to the rules of the SEC, Part IV, Item 15 (Exhibit Index) has also been amended to contain the currently dated certifications from our principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. The certifications of our principal executive officer and principal financial officer are attached to this Amendment No. 1 as Exhibits 31.1 and 31.2, respectively. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, we have omitted paragraphs 3, 4 and 5 of the certifications filed with this Amendment No. 1. Additionally, we are not including the certifications under Section 906 of the Sarbanes-Oxley Act of 2002, because we are not filing any financial statements with this Amendment No. 1.

     

    This Amendment No. 1 speaks as of the original filing date of the Original Form 10-K. No other information included in the Original Form 10-K has been modified or updated in any way. The Original Form 10-K continues to speak as of the date of the original filing, and the Company has not updated the disclosures contained therein to reflect any events that occurred after the original filing other than as expressly indicated in this Amendment No. 1. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Form 10-K and the Company’s other SEC filings.

     

     

     

     

    Item 15. Exhibits, Financial Statement Schedules.

     

    (a)(3) Exhibits:

     

    The exhibits listed on the Exhibit Index (following the signatures section of this report) are included, or incorporated by reference, in this annual report.

     

    (b) Exhibits:

     

    See Item 15(a)(3) above.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Dated: June 23, 2025

     

      ISRAEL ACQUISITIONS CORP
       
     

    By:

    /s/ Ziv Elul 
        Name: Ziv Elul
        Title: Chief Executive Officer and Director

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

     

    Name   Position   Date
             

    By:

    /s/ Ziv Elul    Chief Executive Officer and Director   June 23, 2025
      Ziv Elul   (Principal Executive Officer)    
               
    By: /s/ Sharon Barzik Cohen    Chief Financial Officer and Director   June 23, 2025
      Sharon Barzik Cohen   (Principal Financial and Accounting Officer)    
               
    By: /s/ Izhar Shay    Director (Chairman)   June 23, 2025
      Izhar Shay        
               
    By: /s/ Candice Beaumont    Director   June 23, 2025
      Candice Beaumont        
               
    By: /s/ Peter Cohen    Director   June 23, 2025
      Peter Cohen        
               
    By: /s/ Roy Zisapel    Director   June 23, 2025
      Roy Zisapel        
               
    By: /s/ Daniel Recanati    Director   June 23, 2025
      Daniel Recanati        

     

     

     

     

    EXHIBIT INDEX

     

            Incorporated by Reference
    Exhibit 
    No.
      Exhibit Description   Form   SEC File
    No.
      Exhibit   Filing
    Date
    1.1   Underwriting Agreement, dated January 12, 2023, by and among the Company and BTIG, LLC, as representative of the several underwriters.   8-K   001-41593   1.1   January 19, 2023
    2.1   Business Combination Agreement, dated as of January 2, 2024, by and between the Company and Pomvom Ltd.   8-K   001-41593   2.1   January 2, 2024
    2.2   Amendment No. 1 to the Business Combination Agreement, dated April 22, 2024, by and between Israel Acquisitions Corp and Pomvom Ltd.   8-K   001-41593   2.2   April 24, 2024
    2.3   Business Combination Agreement, dated as of January 26, 2025, by and among, Israel Acquisitions Corp and Gadfin Ltd.   8-K   001-41593   2.1   January 27, 2025
    3.1   Third Amended and Restated Memorandum and Articles of Association, dated January 8, 2024   8-K   001-41593   3.1   January 11, 2024
    3.2   Fourth Amended and Restated Memorandum and Articles of Association, adopted on January 6, 2025.   8-K   001-41593   3.1   January 10, 2025
    4.1   Specimen Unit Certificate   S-1   333-263658   4.1   August 31, 2022
    4.2   Specimen Class A Ordinary Share Certificate   S-1   333-263658   4.2   August 31, 2022
    4.3   Specimen Warrant Certificate (included in Exhibit 4.4)   S-1   333-263658   4.4   August 31, 2022
    4.4   Warrant Agreement, dated January 12, 2023, by and between the Company and American Stock Transfer & Trust Company, as warrant agent.   8-K   001-41593   4.1   January 19, 2023
    4.5   Description of Securities   10-K   001-41593   4.5   April 17, 2023
    10.1   Letter Agreement, dated January 12, 2023, by and among the Company, its executive officers, its directors and Israel Acquisitions Sponsor LLC.   8-K   001-41593   10.1   January 19, 2023
    10.2   Investment Management Trust Agreement, dated January 12, 2023, by and between the Company and American Stock Transfer & Trust Company, as trustee.   8-K   001-41593   10.2   January 19, 2023
    10.3   Registration Rights Agreement, dated January 12, 2023, by and among the Company, Israel Acquisitions Sponsor LLC, BTIG, LLC, Exos Capital LLC and JonesTrading Institutional Services LLC.   8-K   001-41593   10.3   January 19, 2023
    10.4   Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and Israel Acquisitions Sponsor LLC.   8-K   001-41593   10.4   January 19, 2023
    10.5   Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and BTIG, LLC.   8-K   001-41593   10.5   January 19, 2023

     

     

     

     

    10.6   Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and Exos Capital LLC.   8-K   001-41593   10.6   January 19, 2023
    10.7   Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and JonesTrading Institutional Services LLC.   8-K   001-41593   10.7   January 19, 2023
    10.8   Administrative Services Agreement, dated January 12, 2023, by and between the Company and Israel Acquisitions Sponsor LLC.   8-K   001-41593   10.8   January 19, 2023
    10.9   Form of Indemnity Agreement   S-1   333-263658   10.5   August 31, 2022
    10.10   Promissory Note, dated January 26, 2022, issued to the Sponsor.   S-1   333-263658   10.7   March 17, 2022
    10.11   Securities Subscription Agreement, dated January 26, 2022, between the Company and Israel Acquisitions Sponsor LLC.   S-1   333-263658   10.8   March 17, 2022
    10.12   Sponsor Support Agreement, dated January 2, 2024, by and among the Company, Pomvom Ltd. and Israel Acquisitions Sponsor LLC.   8-K   001-41593   10.1   January 2, 2024
    10.13   Form of Transaction Support Agreement.   8-K   001-41593   10.2   January 2, 2024
    10.14   Form of Registration Rights and Lock-Up Agreement.   8-K   001-41593   10.3   January 2, 2024
    10.15   Amendment to the Investment Management Trust Agreement, dated January 8, 2024, by and between Israel Acquisitions Corp and Equiniti Trust Company, LLC.   8-K   001-41593   10.1   January 11, 2024
    10.16   Amended and Restated Sponsor Support Agreement, dated April 19, 2024, by and among the Company, Pomvom Ltd. and Israel Acquisitions Sponsor LLC.   10-Q   001-41593   10.1   May 15, 2024
    10.17   Promissory Note, dated January 18, 2024, by and between the Company and Israel Acquisitions Sponsor.   10-Q   001-41593   10.5   May 15, 2024
    10.18   Promissory Note, dated July 17, 2024, between the Company and Israel Acquisitions Sponsor LLC.   10-Q    001-41593   10.1    August 14, 2024
    10.19   Amendment to the Investment Management Trust Agreement, dated January 6, 2025, by and between Israel Acquisitions Corp and Equiniti Trust Company, LLC.   8-K   001-41593   10.1   January 10, 2025
    10.20   Promissory Note dated January 17, 2025, by and between the Company and the Sponsor   8-K   001-41593   10.1   January 22, 2025
    10.21   Form of Sponsor Support Agreement.   8-K   001-41593   10.1   January 27, 2025
    10.22   Form of Transaction Support Agreement.   8-K   001-41593   10.2   January 27, 2025
    97.1*   Clawback Policy                
    31.1   Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   10-K   001-41593   31.1   March 31, 2025
    31.2   Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.    10-K   001-41593   31.2   March 31, 2025
    31.3*    Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                 
    31.4*    Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                 

     

     

     

     

    32.1   Certification of Chief Executive Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                
    32.2   Certification of Chief Financial Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                
                         
    101.INS*   XBRL Instance Document                
    101.SCH*   XBRL Taxonomy Extension Schema Document                
    101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document                
    101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document                
    101.LAB*   XBRL Taxonomy Extension Labels Linkbase Document                
    101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document                
    104   Cover Page Interactive Data File. Formatted in Inline XBRL and contained in exhibit 101.                

     

    *Filed herewith

    ** These certifications are being furnished solely to accompany this annual report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

     

     

     

     

     

    Get the next $ISRL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ISRL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ISRL
    SEC Filings

    View All

    SEC Form DEF 14A filed by Israel Acquisitions Corp

    DEF 14A - Israel Acquisitions Corp (0001915328) (Filer)

    12/29/25 4:19:28 PM ET
    $ISRL
    Blank Checks
    Finance

    SEC Form PRE 14A filed by Israel Acquisitions Corp

    PRE 14A - Israel Acquisitions Corp (0001915328) (Filer)

    12/16/25 6:03:17 AM ET
    $ISRL
    Blank Checks
    Finance

    SEC Form 425 filed by Israel Acquisitions Corp

    425 - Israel Acquisitions Corp (0001915328) (Subject)

    12/2/25 5:22:44 PM ET
    $ISRL
    Blank Checks
    Finance

    $ISRL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gadfin Ltd. and Israel Acquisitions Corp. Announce Entry into Definitive Business Combination Agreement, Bringing the Unmanned Aerial Delivery Company to Nasdaq

    TEL-AVIV, Israel, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Israel Acquisitions Corp. (NASDAQ:ISRL, ISRLU, ISRLW)), ("ISRL"), a publicly-traded special purpose acquisition company, and Gadfin Ltd. ("Gadfin"), an Israeli technology company specializing in all-weather, long range, heavy-duty, drone delivery for essential cargo, today announced the entry into a definitive business combination agreement reflecting a total equity value of Gadfin of up to $200 million USD (the "Business Combination Agreement"). The combined company will trade on Nasdaq and leverage Gadfin's innovative technology augmented with the expertise of the ISRL team. Through Gadfin's patented technology, its unmanned aerial v

    1/27/25 7:00:00 AM ET
    $ISRL
    Blank Checks
    Finance

    Israel Acquisitions Corp. Announces LOI with Gadfin Aero-Logistics Systems

    TEL AVIV, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Israel Acquisitions Corp. (NASDAQ:ISRL) today announced that it has signed a non-binding letter of intent ("LOI") for a proposed business combination (the "Combination") with Gadfin Aero-Logistics Systems ("Gadfin"), an Israeli technology company specializing in all-weather unmanned aerial delivery for necessary cargo such as medical supplies. Through the company's patented technology, its unmanned aerial vehicles, powered by Hydrogen Fuel cells, that are able to deliver medical supplies and other cargo with ease, even under harsh weather conditions to long range destinations. This makes it possible to significantly improve logistics delivery in

    10/16/24 4:30:15 PM ET
    $ISRL
    Blank Checks
    Finance

    Israel Acquisitions Corp. and Pomvom Ltd. announce a mutual termination of the Business Combination Agreement

    TEL-AVIV, Israel, Aug. 22, 2024 /PRNewswire/ -- Israel Acquisitions Corp (NASDAQ:ISRL) (NASDAQ:ISRLU) (NASDAQ:ISRLW) ("ISRL"), a publicly-traded special purpose acquisition company, Pomvom Ltd. (TASE: PMVM) ("Pomvom"), an Israeli technology company developing and providing experiential content to amusement parks and attractions globally, announced today that they have signed a mutual termination and release agreement (the "Termination Agreement") to terminate the Business Combination Agreement and additional related agreements (the "Merger Agreement"), due to the change in global market conditions. Pursuant to the Termination Agreement, the parties also mutually agreed to waive any claim or

    8/22/24 9:04:00 AM ET
    $ISRL
    Blank Checks
    Finance

    $ISRL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Israel Acquisitions Sponsor Llc

    4 - Israel Acquisitions Corp (0001915328) (Issuer)

    5/9/23 5:00:49 PM ET
    $ISRL
    Blank Checks
    Finance

    SEC Form 4 filed by Ecalle Charles

    4 - Israel Acquisitions Corp (0001915328) (Issuer)

    5/9/23 4:57:45 PM ET
    $ISRL
    Blank Checks
    Finance

    SEC Form 4 filed by Greystoke Alexander

    4 - Israel Acquisitions Corp (0001915328) (Issuer)

    5/9/23 4:55:22 PM ET
    $ISRL
    Blank Checks
    Finance

    $ISRL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Israel Acquisitions Corp

    SC 13G - Israel Acquisitions Corp (0001915328) (Subject)

    11/14/24 8:57:28 PM ET
    $ISRL
    Blank Checks
    Finance

    SEC Form SC 13G filed by Israel Acquisitions Corp

    SC 13G - Israel Acquisitions Corp (0001915328) (Subject)

    11/13/24 4:11:31 PM ET
    $ISRL
    Blank Checks
    Finance

    SEC Form SC 13G filed by Israel Acquisitions Corp

    SC 13G - Israel Acquisitions Corp (0001915328) (Subject)

    11/13/24 11:54:04 AM ET
    $ISRL
    Blank Checks
    Finance